Isolation and whole genome sequencing of a lipophilic anaerobic bacterium, a representative of the species complex Corynebacterium tuberculostearicum, from a tuberculosis focus

Background. The study of the lower respiratory tract microbiome has been actively developed inrecent years with the help of whole genome sequencing (WGS) methods. Due to this, it became clear that the nature of the lungs microbiota is very different from other microbial communities inhabiting the human body. One of the important directions in the study of pathological lungs biocenosis is the study of the role of the satellite microbiota of the tuberculosis focus.

The aim of the work. To isolate and characterize oxygen-tolerant anaerobes from the necrotic contents of tuberculomas.

Materials and methods. Biopsy material from 5 patients with pulmonary tuberculosis was obtained during a planned surgical treatment of tuberculoma. A pure culture was isolated from one sample during anaerobic cultivation. Lipase activity of strain was determined by plating on brain heart infusion agar (HIMEDIA, India) supplemented with 0.1 % Tween-80 and 10 mM of CaCl₂. Antibiotic susceptibility was determined by RAPMYCO and SLOWMYCO of TREK Diagnostic Systems (Thermo Fisher Scientific, USA). DNA from the sediment of the broth culture was isolated by the CTAB chloroform method. Whole genome sequencing was performed on a DNBSeq-G400 NGS sequencer by Genomed (Russia).

Results. Based on WGS results and phylogenetic analysis, the strain was identified as Corynebacterium kefirresidentii. The strain was characterized by high lipase activity and resistance only to Isoniazid, Ethionamide and Trimethoprim/Sulfamethoxazolin.

Conclusion. The isolation of a lipophilic anaerobic representative of the Corynebacterium tuberculostearicum species complex from a tuberculous focus indicates a  possible role of the non-tuberculous microbiota in the liquefaction of caseous necrosis. We assumed that in some cases, favorable conditions are created inside the tuberculous focus for the development of satellite anaerobic lipophilic microbiota.

1. Natalini JG, Singh S, Segal LN. The dynamic lung microbiome in health and disease. Nat Rev Microbiol. 2023; 21: 222-235. doi: 10.1038/s41579-022-00821-x

2. Man W, de Steenhuijsen Piters W, Bogaert D. The microbiota of the respiratory tract: Gatekeeper to respiratory health. Nat Rev Microbiol. 2017; 15: 259-270. doi: 10.1038/nrmicro.2017.14

3. Remot A, Descamps D, Noordine ML, Boukadiri A, Mathieu E, Robert V, et al. Bacteria isolated from lung modulate asthma susceptibility in mice. ISME J. 2017; 11(5): 1061-1074. doi: 10.1038/ismej.2016.181

4. Hilty M, Burke C, Pedro H, Cardenas P, Bush A, Bossley C, et al. Disordered microbial communities in asthmatic airways. PLoS One. 2010; 5(1): e8578. doi: 10.1371/journal.pone.0008578

5. Guarner F, Malagelada JR. Gut flora in health and disease. Lancet. 2003; 361(9356): 512-519. doi: 10.1016/S0140-6736(03)12489-0

6. de Steenhuijsen Piters WAA, Binkowska J, Bogaert D. Early life microbiota and respiratory tract infections. Cell Host Microbe. 2020; 12; 28(2): 223-232. doi: 10.1016/j.chom.2020.07.004

7. Orlova EA, Ogarkov OB, Suzdalnitskiy AE, Khromova PA, Sinkov VV, Plotnikov AO, et al. Analysis of microbial diversity in caseous necrosis of tuberculosis foci. Mol Genet Microbiol Virol. 2021; (36): 132-138. doi: 10.3103/S0891416821030058

8. Ogarkov OB, Suzdalnitsky AE, Khromova PA, Tsyrenova TA, Sokolnikova NA, Zhdanova SN, et al. Biofilm formation induced by clinical isolates of mycobacterium tuberculosis. Russian Journal of Infection and Immunity. 2018; 8(4): 435-440. (In Russ.). doi: 10.15789/2220-7619-2018-4-435-440

9. Ogarkov OB, Badleeva V, Belkova NL, Adelshin RV, Tsyrenova TA, Khromova PA, et al. The phenomenon of the formation of biofilms by Brevibacillus spp. and Bacillus spp. in the presence of clinical strains of Mycobacterium tuberculosis. Mol Genet Microbiol Virol. 2017; (32): 148-154. doi: 10.3103/S0891416817030065

10. Cronan MR. In the thick of it: Formation of the tuberculous granuloma and its effects on host and therapeutic responses. Front Immunol. 2022; 7(13): 820134. doi: 10.3389/fimmu.2022.820134

11. Kholodok OA, Grigorenko AA, Cheryemkin MI. Pulmonary tuberculoma as a form of tuberculous process. Bulletin Physiology and Pathology of Respiration. 2014; (53): 126-131. (In Russ.).

12. Russell DG, Cardona PJ, Kim MJ, Allain S, Altare F. Foamy macrophages and the progression of the human tuberculosis granuloma. Nat Immunol. 2009; 10(9): 943-948. doi: 10.1038/ni.1781

13. Brown-Elliott BA, Woods GL. Antimycobacterial susceptibility testing of nontuberculous mycobacteria. J Clin Microbiol. 2019; 57(10): e00834-19. doi: 10.1128/JCM.00834-19

14. Medvedeva TV, Ogarkov OB, Nekipelova OM, Ushakov IV, Kozyakova ES, Skvortsova RG. MIRU-VNTR genotyping of Mycobacterium tuberculosis strains from East Siberia: Beijing family versus Kilimanjaro family. Molecular Genetics, Microbiology and Virology. 2004; (4): 33-38. (In Russ.).

15. Prjibelski A, Antipov D, Meleshko D, Lapidus A, Korobeynikov A. Using SPAdes de novo assembler. Curr Prot Bioinform. 2020; 70(1): e102. doi: 10.1002/cpbi.102

16. Tamames J, Puente-Sánchez F. SqueezeMeta, a highly portable, fully automatic metagenomic analysis pipeline. Front Microbiol. 2019; 9: 3349. doi: 10.3389/fmicb.2018.03349

17. Meier-Kolthoff JP, Auch AF, Klenk HP, Göker M. Genome sequence-based species delimitation with confidence intervals and improved distance functions. BMC Bioinformatics. 2013; 14: 1-14. doi: 10.1186/1471-2105-14-60

18. Katoh K, Standley DM. MAFFT multiple sequence alignment software version 7: Improvements in performance and usability. Mol Biol Evol. 2013; 30(4): 772-780. doi: 10.1093/molbev/mst010

19. Minh BQ, Schmidt HA, Chernomor O, Schrempf D, Woodhams MD, von Haeseler A, et al. IQ-TREE 2: New models and efficient methods for phylogenetic inference in the genomic era. Mol Biol Evol. 2020; 37(5): 1530-1534. doi: 10.1093/molbev/msaa015

20. Edgar RC. Updating the 97 % identity threshold for 16S ribosomal RNA OTUs. Bioinformatics. 2018; 34(14): 2371-2375. doi: 10.1093/bioinformatics/bty113

21. Boxberger M, Antezack A, Magnien S, Cassir N, La Scola B. Complete genome and description of Corynebacterium incognita sp. nov.: A new bacterium within the Corynebacterium genus. New Microbes New Infect. 2021; 42: 100893. doi: 10.1016/j.nmni.2021.100893

22. Council SE, Savage AM, Urban JM, Ehlers ME, Skene JH, Platt ML, et al. Diversity and evolution of the primate skin microbiome. Proc Biol Sci. 2016; 283(1822): 20152586. doi: 10.1098/rspb.2015.2586

23. Salamzade R, Swaney MH, Kalan LR. Comparative genomic and metagenomic investigations of the Corynebacterium tuberculostearicum species complex reveals potential mechanisms underlying associations to skin health and disease. Microbiol Spectr. 2023; 11(1): e0357822. doi: 10.1128/spectrum.03578-22

24. Dover LG, Thompson AR, Sutcliffe IC, Sangal V. Phylogenomic reappraisal of fatty acid biosynthesis, mycolic acid biosynthesis and clinical relevance among members of the genus Corynebacterium. Front Microbiol. 2021; 12: 802532. doi: 10.3389/fmicb.2021.802532

25. Morlock GP, Metchock B, Sikes D, Crawford JT, Cooksey RC. ethA, inhA, and katG loci of ethionamide-resistant clinical Mycobacterium tuberculosis isolates. Antimicrob Agents Chemother. 2003; 47(12): 3799-3805. doi: 10.1128/AAC.47.12.3799-3805.2003